Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens

In VitroInteractions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development

(2011) Maria Souli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Beyond serial passages: new methods for predicting the emergence of resistance to novel antibiotics

(2011) José Luis Martínez et al.   CURRENT OPINION IN PHARMACOLOGY

Therapeutic options for infections withEnterobacteriaceaeproducing carbapenem-hydrolyzing enzymes

(2011) Matthew E Falagas et al.   Future Microbiology

Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials

(2011) T. D. Thi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pseudomonas aeruginosa fosfomycin resistance mechanisms affect non-inherited fluoroquinolone tolerance

(2011) V. N. De Groote et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies

(2011) M. Fauvart et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Prevalence of Fosfomycin Resistance among CTX-M-Producing Escherichia coli Clinical Isolates in Japan and Identification of Novel Plasmid-Mediated Fosfomycin-Modifying Enzymes

(2010) J.-i. Wachino et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Frequency of Spontaneous Resistance to Fosfomycin Combined with Different Antibiotics in Pseudomonas aeruginosa

(2010) A. Rodriguez-Rojas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial susceptibility of Gram-positive non-urinary isolates to fosfomycin

(2010) Matthew E. Falagas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli

(2010) Sho Takahata et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Extracellular concentrations of fosfomycin in lung tissue of septic patients

(2010) V. Matzi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials

(2010) Matthew E. Falagas et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections

(2010) Alexandro Rodríguez-Rojas et al.   PLoS One

Identification of a novel UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Vibrio fischeri that confers high fosfomycin resistance in Escherichia coli

(2009) Sanath Kumar et al.   ARCHIVES OF MICROBIOLOGY

Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections

(2009) Nikos Roussos et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis

(2009) D. L. MacLeod et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model

(2009) Y. Cai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin

(2009) J. Oteo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Glycerol-3-Phosphate Permease GlpT Is the Only Fosfomycin Transporter in Pseudomonas aeruginosa

(2009) A. Castaneda-Garcia et al.   JOURNAL OF BACTERIOLOGY

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review

(2009) Matthew E Falagas et al.   LANCET INFECTIOUS DISEASES

Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin

(2008) M. E. Falagas et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Etiología de la infección urinaria baja adquirida en la comunidad y resistencia de Escherichia coli a los antimicrobianos de primera línea. Estudio nacional multicéntrico

(2008) Antonia Andreu et al.   MEDICINA CLINICA